Loading institutional data...
Loading institutional data...
Held by 354 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 259 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIN | $230.5B | 33.6× | 20.6× | 6.8× | 3.0% | — | 20.3% | 18.0% | 10.9% | 2.1× | 2,148 |
| BHPLF | $220.3B | — | — | — | — | — | — | — | — | — | 6 |
| SCCO | $162.8B | 37.6× | 21.0× | 12.1× | 17.4% | 60.1% | 32.3% | 39.3% | 24.4% | 0.9× | 791 |
| TX | $107.7B | — | — | — | — | — | — | — | — | — | 139 |
| FCX | $99.7B | — | 12.0× | 3.9× | 1.8% | 28.2% | 8.5% | 11.7% | 7.9% | 1.0× | 1,775 |
| SHW | $91.6B | 36.0× | — | 3.9× | 2.1% | 48.8% | 10.9% | 55.9% | 17.0% | — | 1,610 |
| AEM | $82.8B | — | — | — | — | — | — | — | — | — | 1,066 |
| ECL | $80.5B | 39.2× | 23.7× | 5.0× | 2.2% | 44.5% | 12.9% | 21.2% | 19.5% | 0.3× | 1,619 |
| B | $68.8B | — | — | — | — | — | — | — | — | — | 979 |
| CRH | $66.9B | 18.1× | 10.4× | 1.8× | 5.3% | 36.1% | 10.0% | 15.6% | 9.2% | 2.2× | 9 |
| APD | $65.7B | — | 92.9× | 5.5× | -0.5% | 31.4% | -3.3% | -2.6% | -2.6% | 0.1× | 1,702 |
| VALE | $63.6B | — | — | — | — | — | — | — | — | — | 537 |
| SYAXF | $63.5B | — | — | — | — | — | — | — | — | — | — |
| DD | $61.5B | — | — | 9.0× | 1.9% | 34.5% | 1.3% | 0.6% | 0.6% | — | 1,172 |
| WPM | $55.8B | — | — | — | — | — | — | — | — | — | 809 |
| AU | $44.7B | — | — | — | — | — | — | — | — | — | 537 |
| FNV | $43.7B | — | — | — | — | — | — | — | — | — | 614 |
| STLD | $38.5B | 33.3× | 20.7× | 2.1× | 3.6% | 13.2% | 6.5% | 13.2% | 9.0% | 2.1× | 893 |
| VMC | $37.5B | 35.4× | 17.6× | 4.7× | 7.1% | 27.4% | 13.6% | 12.6% | 8.4% | 1.8× | 981 |
| MLM | $33.4B | 29.5× | 18.6× | 5.4× | 8.6% | 30.7% | 18.5% | 11.3% | 7.4% | 2.6× | 1,022 |
| TCKRF | $32.4B | — | — | — | — | — | — | — | — | — | 8 |
| NTR | $32.1B | — | — | — | — | — | — | — | — | — | 718 |
| AMRZ | $29.2B | 24.7× | 12.1× | 2.5× | 0.9% | 25.7% | 10.0% | 8.9% | 6.5% | 1.9× | 433 |
| GFIOF | $28.7B | — | — | — | — | — | — | — | — | — | 4 |
| PPG | $26.6B | 17.2× | — | 1.7× | 0.2% | 41.3% | 9.9% | 19.8% | 10.8% | — | 1,003 |
| CBT | $4.5B | 14.0× | 6.5× | 1.2× | -7.0% | 25.3% | 8.9% | 21.4% | 13.7% | 1.1× | 354 |
Peers = companies sharing CBT's sector (Basic Materials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 14%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $258M covers the $4M due within a year 64.5× over. Scheduled principal only (excludes interest & revolver draws). As of 2024-09-30 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~8.7% on $870M of debt.
Cash of $258M fully covers short-term debt of $14M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.71B 100.0% | $3.99B 100.0% | $3.93B 100.0% | $4.32B 100.0% | $3.41B 100.0% | $2.61B 100.0% | $3.34B 100.0% | $3.24B 100.0% | $2.72B 100.0% | $2.41B 100.0% |
| Cost of Revenue | $2.77B 74.7% | $3.03B 76.0% | $3.09B 78.7% | $3.44B 79.5% | $2.61B 76.6% | $2.11B 80.9% | $2.65B 79.5% | $2.47B 76.2% | $2.06B 75.8% | $1.84B 76.2% |
| Gross Profit | $940.0M 25.3% | $960.0M 24.0% | $839.0M 21.3% | $885.0M 20.5% | $799.0M 23.4% | $500.0M 19.1% | $685.0M 20.5% | $772.0M 23.8% | $657.0M 24.2% | $575.0M 23.8% |
| Research & Development | $59.0M 1.6% | $63.0M 1.6% | $57.0M 1.5% | $55.0M 1.3% | $56.0M 1.6% | $57.0M 2.2% | $60.0M 1.8% | $66.0M 2.0% | $57.0M 2.1% | $53.0M 2.2% |
| Selling, General & Admin | $260.0M 7.0% | $283.0M 7.1% | $253.0M 6.4% | $258.0M 6.0% | $289.0M 8.5% | $292.0M 11.2% | $290.0M 8.7% | $308.0M 9.5% | $262.0M 9.6% | $275.0M 11.4% |
| Operating Income | $621.0M 16.7% | $614.0M 15.4% | $526.0M 13.4% | $389.0M 9.0% | $454.0M 13.3% | $21.0M 0.8% | $306.0M 9.2% | $144.0M 4.4% | $338.0M 12.4% | $247.0M 10.2% |
| Interest Expense | $76.0M 2.0% | $81.0M 2.0% | $90.0M 2.3% | $56.0M 1.3% | $49.0M 1.4% | $53.0M 2.0% | $59.0M 1.8% | $54.0M 1.7% | $53.0M 2.0% | $54.0M 2.2% |
| Other Income (Expense), net | -$7.0M -0.2% | -$36.0M -0.9% | -$16.0M -0.4% | -$9.0M -0.2% | -$7.0M -0.2% | -$9.0M -0.3% | -$1.0M -0.0% | $17.0M 0.5% | $5.0M 0.2% | -$7.0M -0.3% |
| Pretax Income | $565.0M 15.2% | $529.0M 13.2% | $451.0M 11.5% | $335.0M 7.8% | $406.0M 11.9% | -$33.0M -1.3% | $255.0M 7.6% | $117.0M 3.6% | $299.0M 11.0% | $191.0M 7.9% |
| Income Tax Expense | $196.0M 5.3% | $111.0M 2.8% | -$28.0M -0.7% | $102.0M 2.4% | $123.0M 3.6% | $191.0M 7.3% | $70.0M 2.1% | $193.0M 6.0% | $33.0M 1.2% | $33.0M 1.4% |
| Net Income | $331.0M 8.9% | $380.0M 9.5% | $445.0M 11.3% | $209.0M 4.8% | $250.0M 7.3% | -$238.0M -9.1% | $157.0M 4.7% | -$113.0M -3.5% | $248.0M 9.1% | $147.0M 6.1% |
| Per Share | ||||||||||
| EPS (Basic) | $6.07 | $6.79 | $7.79 | $3.65 | $4.35 | $-4.21 | $2.64 | $-1.85 | $3.94 | $2.34 |
| EPS (Diluted) | $6.02 | $6.72 | $7.73 | $3.62 | $4.34 | $-4.21 | $2.63 | $-1.85 | $3.91 | $2.32 |
| Weighted Avg Shares (Basic) | 53.7M | 55.1M | 56.1M | 56.5M | 56.7M | 56.6M | 58.7M | 61.7M | 62.3M | 62.4M |
| Weighted Avg Shares (Diluted) | 54.2M | 55.7M | 56.5M | 56.9M | 56.8M | 56.6M | 58.8M | 61.7M | 62.7M | 62.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $84.54 today, the market must believe free cash flow compounds 1.6%/yr for a decade (off $398M normalized FCF).
The market's 1.6% is more conservative than its 9-yr track record.
2-stage DCF · 0.05B shares · net debt $612M
mean -36.7% · volatility σ 112% · implied rate exceeded in 3/8 yrs
Central path = implied 1.6%/yr growth; shaded band = ±1σ (112%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 25% of free cash flow, leaving room to grow it and fund buybacks. Last year: $96M dividends + $168M buybacks = $264M returned on $391M FCF.
4 consecutive years of dividend increases · 6%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-08-05
Nothing notable to watch.
No material risks flagged.
Where each multiple sits in its own 14-yr range · 70th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 76.2 | 79.5 | 80.9 | 76.6 | 79.5 | 78.7 | 76.0 | 74.7 |
| Gross Profit | 23.8 | 20.5 | 19.1 | 23.4 | 20.5 | 21.3 | 24.0 | 25.3 |
| R&D | 2.0 | 1.8 | 2.2 | 1.6 | 1.3 | 1.5 | 1.6 | 1.6 |
| SG&A | 9.5 | 8.7 | 11.2 | 8.5 | 6.0 | 6.4 | 7.1 | 7.0 |
| Operating Income | 4.4 | 9.2 | 0.8 | 13.3 | 9.0 | 13.4 | 15.4 | 16.7 |
| Income Tax | 6.0 | 2.1 | 7.3 | 3.6 | 2.4 | -0.7 | 2.8 | 5.3 |
| Net Income | -3.5 | 4.7 | -9.1 | 7.3 | 4.8 | 11.3 | 9.5 | 8.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CBT: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.